The Role Of Fibroblast Growth Factor Receptor 4 (Fgfr4) Signaling In Anti-Egfr Resistance In Colon Cancer.
JOURNAL OF CLINICAL ONCOLOGY(2020)
摘要
4060Background: Anti-EGFR therapy has been used as a standard treatment for metastatic colon cancer, but the innate resistance is still issues of increasing significance. Fibroblast growth factor r...
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要